Skip to main content
    AngelBacked

    Kymera Therapeutics

    BiotechnologyCambridge, Massachusetts, United StatesPost-IPO Equity$2.0B total fundingwww.kymeratx.com
    Latest funding:$602.0M · Post-IPO Equity (December 10, 2025)

    Angel investors who backed Kymera Therapeutics

    35 investors in our database backed Kymera Therapeutics.

    Jason Mehring

    Managing Director

    Laurence Paredes

    Private Debt Product Structuring & Fund Board Engagement Lead / Global Private Debt

    Jim Keenan

    MD

    Daniel Nellis

    Director - US Private Capital

    Rob DiPaolo

    Managing Director

    Michael Pungello

    Interim CFO and Treasurer

    R. Marshall Merriman

    Managing Director

    Nik Singhal

    Managing Director

    Andrew Norman

    Vice President

    Michael Leitner

    Managing Director

    Rob Faulkner

    Board Member

    Gerard van Hamel Platerink

    Managing Director

    Kevin Bitterman

    Partner

    Bruce Booth

    Partner

    Jason Rhodes

    Partner

    Jernej Godec

    Principal

    Alex Harding

    Senior Associate

    Jean-FranÔøΩEois Formela

    Partner

    Chelsea Place Johnson

    Senior Associate

    Ommer Chohan

    CFO

    Steven Robinette

    Principal

    John Crumpler

    General Partner

    Clay Thorp

    General Partner

    Ben Scruggs

    Partner

    Fred Goldwater

    Venture Partner

    Robert Morff

    Venture Partner

    Christopher Gagliardi

    Principal, Sanofi Ventures

    Jason P. Hafler

    Managing Director

    Laia Crespo

    Partner - Sanofi Ventures

    Daniel Mansuri

    Director of Investments

    Leon Chen

    CEO and Founding Partner

    Ching Zhu

    Managing Partner

    John Zhu

    Venture Partner

    Rebecca Zhu

    Partner

    Erdong Hua

    Partner

    View the full investor list for Kymera Therapeutics

    Find the right investors for your startup

    Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Kymera Therapeutics.

    Search investors